Sites / Iowa Diabetes and Endocrinology Research Center
Is this you?

Request access for Iowa Diabetes and Endocrinology Research Center with your @iowadiabetes.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Iowa Diabetes and Endocrinology Research Center

Unclaimed profile

Independent Site · Iowa · ~1 sites

Intera lens
ICP 6Lift (cardio sample) 0.14Recruit soph 0.86
Quality Scorecard (1–100)
Overall67Recruit78Ops71Sponsor57Ther58

Performance (observed)

Historical trials
170
Completed
103
Terminated/Withdrawn
21
Completion rate
83%
Active now
44
Phase 2
36
Phase 3
102
Realized enrollment
297,757
First study year
2002
Years active
24
Match confidence
high
Enrollment velocity (inf)
12,407

Therapeutic

Areas
Diabetes, Endocrinology, Obesity, Metabolic Disorders
Specialties
Diabetes, Type 1 & Type 2, Obesity, Metabolic disorders
Breadth (conditions)
76
States
Iowa

Recruitment (web observed)

Meta Pixel
Yes
Facebook Ads
Yes
Google Ads
Yes
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong organic presence; active trial recruitment
Capability notes
High - Research-focused with 100+ years combined expertise

Relationships

Sponsors
Eli Lilly and Company; Novo Nordisk A/S; Jaeb Center for Health Research; Boehringer Ingelheim; Medtronic MiniMed, Inc.; Pfizer
CROs
MacroGenics; Medpace, Inc.
Partnerships
University of Iowa (FOE Diabetes Research Center)
Owner / parent
Independent (LLC)
Funding
FOE (Fraternal Order of Eagles) $25M pledge to U of Iowa DRC

Capacity & people

Investigators
Coordinators
CEO
Anuj Bhargava, MD, MBA, CDCES, FACP, FACE (Founder)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
choffman@iderc.com

Tech & DCT

eSource
Yes
Builds tech
Y
Tech stack
Technology-driven diabetes care platform
Recruiting visible
Y

Notes

Founded 1994. ClinicalTrials.gov validation: 8 active recruiting cardiometabolic trials. 230+ clinical trials conducted. Founder-led with strong mission focus on diabetes research and technology. Team-based, technology-driven approach. Single location but high volume recruitment.

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.14Overall67

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.